WallStreetZenWallStreetZen

NASDAQ: MDRX
Veradigm Inc Stock

$13.05+0.14 (+1.08%)
Updated Mar 31, 2023
MDRX Price
$13.05
Fair Value Price
$16.73
Market Cap
$1.43B
52 Week Low
$12.64
52 Week High
$23.25
P/E
29x
P/B
1.21x
P/S
2.02x
PEG
N/A
Dividend Yield
N/A
Revenue
$837.19M
Earnings
$60.63M
Gross Margin
48.4%
Operating Margin
9.33%
Profit Margin
7.2%
Debt to Equity
0.44
Operating Cash Flow
$161M
Beta
0.98
Next Earnings
May 3, 2023
Ex-Dividend
N/A
Next Dividend
N/A

MDRX Overview

Allscripts Healthcare Solutions, Inc., together with its subsidiaries, provides information technology solutions and services to healthcare organizations in the United States, Canada, and internationally. It offers electronic health records (EHR), information connectivity, private cloud hosting, outsourcing, analytics, patient access, and population health management solutions. The company operates through two segments, Hospitals and Large Physician Practices, and Veradigm. The Hospitals and Large Physician Practices segment provides integrated clinical and financial management solutions, which primarily include EHR-related software; and related installation, support and maintenance, outsourcing, private cloud hosting, and revenue cycle management services. The Veradigm segment offers payer and life sciences solutions, which are primarily targeted at payers, life sciences companies, and other healthcare stakeholders; and software applications for patient engagement and EHR software to single-specialty, and small and mid-sized physician practices, including related clinical, financial, administrative, and operational solutions. Its solutions enable clients to transition, analyze, and coordinate care, and enhance the healthcare delivery across the care community. The company serves physicians, hospitals, governments and militaries, health systems, health plans, life-sciences companies, retail clinics, surgery centers, retail pharmacies, pharmacy benefit managers, insurance companies, employer wellness clinics, consumers, lab companies, urgent care facilities, and venture capital firms, as well as post-acute organizations, such as home health and hospice agencies. Allscripts Healthcare Solutions, Inc. was founded in 1986 and is headquartered in Chicago, Illinois.

Zen Score

Industry Average (24)
You've viewed Zen Score for 10/10 free stocks. Upgrade to Premium to see how MDRX scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.

Due Diligence Checks

MDRX ($13.05) is undervalued by 22% relative to our estimate of its Fair Value price of $16.73 based on Discounted Cash Flow (DCF) modelling, but does not have a significant margin of safety
Below Fair Value Valuation
MDRX ($13.05) is significantly undervalued by 22% relative to our estimate of its Fair Value price of $16.73 based on Discounted Cash Flow (DCF) modelling, which includes a healthy margin of safety
Significantly Below Fair Value Valuation
MDRX was unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation
There are 30 more MDRX due diligence checks available for Premium users.

Be the first to know about important MDRX news, forecast changes, insider trades & much more!

MDRX News

Valuation

MDRX fair value

Fair Value of MDRX stock based on Discounted Cash Flow (DCF)
Price
$13.05
Fair Value
$16.73
Undervalued by
22.00%
MDRX ($13.05) is undervalued by... subscribe to Premium to read more.
Below Fair Value Valuation
MDRX ($13.05) is significantly undervalued... subscribe to Premium to read more.
Significantly Below Fair Value Valuation
MDRX was unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation

MDRX price to earnings (PE)

For valuing profitable companies with steady earnings
Company
29x
Industry
-0.04x
Market
22.13x
MDRX is good value based... subscribe to Premium to read more.
P/E vs Industry Valuation
MDRX is poor value based... subscribe to Premium to read more.
P/E vs Market Valuation

MDRX price to book (PB)

For valuing companies that are loss-making or have lots of physical asset
Company
1.21x
Industry
3.44x
MDRX is good value based... subscribe to Premium to read more.
P/B vs Industry Valuation

MDRX's financial health

Profit margin

Revenue
$151.9M
Net Income
$14.5M
Profit Margin
9.6%
MDRX's Earnings (EBIT) of $78.13M... subscribe to Premium to read more.
Interest Coverage Financials
MDRX's profit margin has decreased... subscribe to Premium to read more.
Profit Margin Growth Financials

Assets to liabilities

Assets
$1.7B
Liabilities
$513.6M
Debt to equity
0.44
MDRX's short-term assets ($810.77M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
MDRX's short-term assets ($810.77M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
MDRX's debt relative to shareholder... subscribe to Premium to read more.
Shrinking Debt Financials
MDRX's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials

Cash flow

Operating
$28.1M
Investing
-$9.3M
Financing
-$38.5M
MDRX's operating cash flow ($160.81M)... subscribe to Premium to read more.
Debt Coverage Financials

MDRX vs Health Information Service Stocks

TickerMarket Cap1d %P/EP/B
MDRX$1.43B+1.08%29.00x1.21x
NXGN$1.15B+1.69%51.21x2.75x
DH$1.71B+6.28%-172.17x1.80x
PHR$1.72B+4.67%-9.61x5.99x
ACCD$1.05B+5.97%-2.16x2.15x

Veradigm Stock FAQ

What is Veradigm's quote symbol?

NASDAQ: MDRX) Veradigm trades on the NASDAQ under the ticker symbol MDRX. Veradigm stock quotes can also be displayed as NASDAQ: MDRX.

If you're new to stock investing, here's how to buy Veradigm stock.

What is the 52 week high and low for Veradigm (NASDAQ: MDRX)?

(NASDAQ: MDRX) Veradigm's 52-week high was $23.25, and its 52-week low was $12.64. It is currently -43.87% from its 52-week high and 3.24% from its 52-week low.

How much is Veradigm stock worth today?

(NASDAQ: MDRX) Veradigm currently has 109,259,776 outstanding shares. With Veradigm stock trading at $13.05 per share, the total value of Veradigm stock (market capitalization) is $1.43B.

Veradigm stock was originally listed at a price of $16.88 in Jul 26, 1999. If you had invested in Veradigm stock at $16.88, your return over the last 23 years would have been -22.69%, for an annualized return of -1.11% (not including any dividends or dividend reinvestments).

How much is Veradigm's stock price per share?

(NASDAQ: MDRX) Veradigm stock price per share is $13.05 today (as of Mar 31, 2023).

What is Veradigm's Market Cap?

(NASDAQ: MDRX) Veradigm's market cap is $1.43B, as of Apr 1, 2023.

Market cap (market capitalization) is the total market value of a publicly traded company's outstanding shares.

Veradigm's market cap is calculated by multiplying MDRX's current stock price of $13.05 by MDRX's total outstanding shares of 109,259,776.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.